Cataract extraction and age-related macular degeneration: Associations, diagnosis and management

References

• Pollack A, Marcovich A, Bukelman A, Zalish M, Oliver M. Development of exudative age-related macular degenera- tion after cataract surgery. Eye. 1997;11:523–530.
   PubMed Web of Science ®Google Scholar
• Council NAE. Vision Research: A National Plan, 1983– 1987. Bethesda, MD: United States Department of Health and Human Services; 1984.
   Google Scholar
• Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933–943.
   PubMed Web of Science ®Google Scholar
• Bressler NM, Bressler SB. Preventative ophthalmology. Age-related macular degeneration. Ophthalmology. 1995; 102:1206–1211.
   Web of Science ®Google Scholar
• Javitt JC, Kendix M, Tielsch JM et al. Geographic varia- tion in utilization of cataract surgery. Med Care. 1995; 33:90–105.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Wang Q, Moss SE. Is age-related maculopathy associated with cataracts? Arch Ophthalmol. 1994;112:191–196.
   PubMedGoogle Scholar
• Klein BE, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol. 1998;116:219–225.
   PubMedGoogle Scholar
• West SK, Rosenthal FS, Bressler NM et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989;107:875–879.
   PubMed Web of Science ®Google Scholar
• Risk factors associated with age-related macular degenera- tion. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Age- Related Eye Disease Study Research Group. Ophthalmol- ogy. 2000;107:2224–2232.
   Google Scholar
• Moorthy RS, Rajeev B, Smith RE, Rao NA. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1994;118:197–204.
   PubMed Web of Science ®Google Scholar
• Chylack LT, Jr. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum. 1977;20:217–223.
   PubMedGoogle Scholar
• Fishman GA, Anderson RJ, Lourenco P. Prevalence of pos- terior subcapsular lens opacities in patients with retinitis pigmentosa. Br J Ophthalmol. 1985;69:263–266.
   PubMed Web of Science ®Google Scholar
• Costello MJ, Lane CW, Hatchell DL, Saloupis P, Cobo LM. Ultrastructure of fiber cells and multilamellar inclusions in experimental diabetes. Invest Ophthalmol Vis Sci. 1993; 34:2174–2185.
   PubMed Web of Science ®Google Scholar
• Mares-Perlman JA, Klein BE, Klein R, Ritter LL. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology. 1994;101:315–325.
   PubMed Web of Science ®Google Scholar
• Miglior S, Marighi PE, Musicco M, Balestreri C, Nicolosi A, Orzalesi N. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Oph- thalmic Epidemiol. 1994;1:93–105.
   PubMedGoogle Scholar
• Taylor HR. Ultraviolet radiation and the eye: an epidemio- logic study. Trans Am Ophthalmol Soc. 1989;87:802– 853.
   Google Scholar
• Chung CP, Hsu SY, Wu WC. Cataract formation after pars plana vitrectomy. Kaohsiung J Med Sci. 2001;17:84–89.
   Google Scholar
• Drews RC. Peripheral iridectomy: fifteen years later. Trans Am Ophthalmol Soc. 1980;78:70–87.
   Google Scholar
• Floman N, Berson D, Landau L. Peripheral iridectomy in closed angle glaucoma – late complications. Br J Ophthal- mol. 1977;61:101–104.
   Google Scholar
• van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, Pameyer JH, de Jong PT. Increased prevalence of disciform macular degeneration after cataract extraction with implan- tation of an intraocular lens. Br J Ophthalmol. 1994; 78:441–445.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progres- sion of age-related maculopathy. Arch Ophthalmol. 1998; 116:506–513.
   PubMedGoogle Scholar
• Wang JJ, Mitchell PG, Cumming RG, Lim R. Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 1999;6:317–326.
   PubMedGoogle Scholar
• Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653–658.
   PubMed Web of Science ®Google Scholar
• Pollack A, Marcovich A, Bukelman A, Oliver M. Age- related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmol- ogy. 1996;103:1546–1554.
   PubMed Web of Science ®Google Scholar
• Lerman S. Radiant energy and the eye. New York: Macmillan Publishing Co.; 1980: p.153.
   Google Scholar
• Stephens RJ, Negi DS, Short SM, van Kuijk FJ, Dratz EA, Thomas DW. Vitamin E distribution in ocular tissues fol- lowing long-term dietary depletion and supplementation a determined by microdissection and gas chromatography- mass spectrometry. Exp Eye Res. 1988;47:237–245.
   PubMedGoogle Scholar
• Miller D. Clinical light damage to the eye. New York: Springer-Verlag; 1987.
   Google Scholar
• Taylor HR, Munoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc. 1990;88:163–173.
   PubMedGoogle Scholar
• Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sun- light and the 5-year incidence of early age-related macu- lopathy: the beaver dam eye study. Arch Ophthalmol. 2001;119:246–250.
   PubMedGoogle Scholar
• Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124:677–682.
   PubMed Web of Science ®Google Scholar
• Gottsch JD, Pou S, Bynoe LA, Rosen GM. Hematogenous photosensitization. A mechanism for the development of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1990;31:1674–1682.
   PubMed Web of Science ®Google Scholar
• Gottsch JD, Bynoe LA, Harlan JB, Rencs EV, Green WR. Light-induced deposits in Bruch’s membrane of protopor- phyric mice. Arch Ophthalmol. 1993;111:126–129.
   PubMedGoogle Scholar
• Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1978; 17:601–607.
   PubMed Web of Science ®Google Scholar
• Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27:145–152.
   PubMed Web of Science ®Google Scholar
• Weiter JJ, Delori FC, Wing GL, Fitch KA. Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol. 1985;99:185–187.
   PubMed Web of Science ®Google Scholar
• Weiter JJ, Delori F, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol. 1988;106:286–292.
   PubMed Web of Science ®Google Scholar
• Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718–729.
   PubMed Web of Science ®Google Scholar
• Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:496–504.
   PubMed Web of Science ®Google Scholar
• Delori FC, Goger DG, Dorey CK. Age-related accumula- tion and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci. 2001;42:1855–1866.
   PubMed Web of Science ®Google Scholar
• Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina. Relationship to lipofuscin accu- mulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691–1699.
   PubMed Web of Science ®Google Scholar
• Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt’s disease–Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1995;36:2327–2331.
   PubMed Web of Science ®Google Scholar
• Wassell J, Davies S, Bardsley W, Boulton M. The photo- reactivity of the retinal age pigment lipofuscin. J Biol Chem. 1999;274:23828–23832.
   PubMed Web of Science ®Google Scholar
• Wihlmark U, Wrigstad A, Roberg K, Nilsson SE, Brunk UT. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. Free Radic Biol Med. 1997;22:1229–1234.
   PubMed Web of Science ®Google Scholar
• Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid com- ponent of lipofuscin. Invest Ophthalmol Vis Sci. 2000;41:2303–2308.
   PubMed Web of Science ®Google Scholar
• Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluo- rophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981–1989.
   PubMed Web of Science ®Google Scholar
• Anderson RM. Visual perceptions and observations of an aphakic surgeon. Percept Mot Skills. 1983;57:1211– 1218.
   Google Scholar
• Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Effect of an ultraviolet-filtering intraocular lens on cystoid macular edema. Ophthalmology. 1985;92:366–369.
   PubMedGoogle Scholar
• Mainster MA. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol. 1986;102:727–732.
   PubMed Web of Science ®Google Scholar
• Hammer HM, Yap M, Weatherill JR. Visual performance in pseudophakia with standard and ultraviolet-absorbing intraocular lenses: a preliminary report. Trans Ophthalmol Soc UK. 1986;105:441–446.
   Google Scholar
• Kirkness CM, Weale RA. Does light pose a hazard to the macula in aphakia? Trans Ophthalmol Soc UK. 1985; 104:699–702.
   Google Scholar
• Mainster MA. Light and macular degeneration: a bio- physical and clinical perspective. Eye. 1987;1:304–310.
   PubMed Web of Science ®Google Scholar
• Corwin JM, Weiter JJ. Immunology of chorioretinal dis- orders. Surv Ophthalmol. 1981;25:287–305.
   Google Scholar
• Kelly PJ, Weiter JJ. Resolution of optic disk neovascular- ization associated with intraocular inflammation. Am J Ophthalmol. 1980;90:545–548.
   PubMed Web of Science ®Google Scholar
• Weiter J, Fine BS. A histologic study of regional choroidal dystrophy. Am J Ophthalmol. 1977;83:741–750.
   PubMed Web of Science ®Google Scholar
• Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated pro- cesses at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–732.
   PubMed Web of Science ®Google Scholar
• Johnson LV, Leitner WP, Staples MK, Anderson DH. Com- plement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887–896.
   PubMed Web of Science ®Google Scholar
• Anderson DH, Hageman GS, Mullins RF et al. Vitronectin gene expression in the adult human retina. Invest Ophthal- mol Vis Sci. 1999;40:3305–3315.
   PubMed Web of Science ®Google Scholar
• Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pig- mented epithelial cells. Faseb J. 1999;13:477–484.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223:69–76.
   PubMed Web of Science ®Google Scholar
• Pavan PR, Margo CE. Submacular neovascular membrane and focal granulomatous inflammation. Ophthalmology. 1996;103:586–589.
   Google Scholar
• Hutchinson AK, Grossniklaus HE, Capone A. Giant-cell reaction in surgically excised subretinal neovascular mem- brane. Arch Ophthalmol. 1993;111:734–735.
   Google Scholar
• Kimura H, Spee C, Sakamoto T et al. Cellular response in subretinal neovascularization induced by bFGF- impregnated microspheres. Invest Ophthalmol Vis Sci. 1999;40:524–528.
   PubMed Web of Science ®Google Scholar
• Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degenera- tion express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37:1929–1934.
   PubMed Web of Science ®Google Scholar
• Vinores SA, Chan CC, Vinores MA et al. Increased vascu- lar endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascular- ization. J Neuroimmunol. 1998;89:43–50.
   PubMed Web of Science ®Google Scholar
• Fine HF, Baffi J, Reed GF, Csaky KG, Nussenblatt RB. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol. 2001;132:794–796.
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrino- gen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Oph- thalmol. 1998;116:583–587.
   PubMed Web of Science ®Google Scholar
• Lopez PF, Grossniklaus HE, Lambert HM et al. Pathologic features of surgically excised subretinal neovascular mem- branes in age-related macular degeneration. Am J Ophthal- mol. 1991;112:647–656.
   PubMed Web of Science ®Google Scholar
• Krzystolik MG, Afshari MA, Adamis AP et al. Prevention of experimental choroidal neovascularization with intra- vitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002;120:338–346.
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experi- mental subretinal neovascularization in the subhuman primate. Arch Ophthalmol. 1985;103:708–711.
   PubMed Web of Science ®Google Scholar
• Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244–250.
   PubMed Web of Science ®Google Scholar
• Foster CS, Fong LP, Singh G. Cataract surgery and intra- ocular lens implantation in patients with uveitis. Ophthal- mology. 1989;96:281–288.
   PubMed Web of Science ®Google Scholar
• Hykin PG, Gregson RM, Stevens JD, Hamilton PA. Extra- capsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology. 1993;100:394–399.
   PubMed Web of Science ®Google Scholar
• Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634.
   PubMedGoogle Scholar
• Severin TD, Severin SL. Pseudophakic cystoid macular edema: a revised comparison of the incidence with intra- capsular and extracapsular cataract extraction. Ophthalmic Surg. 1988;19:116–118.
   Google Scholar
• Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic cystoid mascular edema: five randomized trials. J Am Intraocul Implant Soc. 1985; 11:380–385.
   Google Scholar
• Stark WJ, Jr., Maumenee AE, Fagadau W et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol. 1984; 28 Suppl:442–451.
   Google Scholar
• Chambless WS. Phacoemulsification and the retina: cystoid macular edema. Ophthalmology. 1979;86:2019– 2022.
   Google Scholar
• Moses L. Incidence of cystoid macular edema following cataract extraction with pseudophakos implantation: intra- capsular vs. extracapsular vs. phacoemulsification. J Am Intraocul Implant Soc. 1978;4:17.
   Google Scholar
• Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol. 1992;76:338–341.
   PubMed Web of Science ®Google Scholar
• Shuttleworth GN, Luhishi EA, Harrad RA. Do patients with age related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol. 1998;82:611–616.
   Google Scholar
• Armbrecht AM, Findlay C, Kaushal S, Aspinall P, Hill AR, Dhillon B. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. Br J Ophthalmol. 2000;84:1343–1348.
   PubMed Web of Science ®Google Scholar
• Edwards MG, Schachat AP, Bressler SB, Bressler NM. Outcome of cataract operations performed to permit diag- nosis, to determine eligibility for laser therapy, or to perform laser therapy of retinal disorders. Am J Ophthal- mol. 1994;118:440–444.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Sperduto RD et al. Dietary carotenoids, vitamins A, C, and E, and advanced age- related macular degeneration. Eye Disease Case-Control Study Group. Jama. 1994;272:1413–1420.
   PubMed Web of Science ®Google Scholar
• A randomized, placebo-controlled, clinical trial of high- dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–1436.
   PubMed Web of Science ®Google Scholar